TAR-200, a gemcitabine-releasing system, received FDA priority review for high-risk non-muscle invasive bladder cancer unresponsive to BCG. Phase 2b SunRISe-1 trial data showed an 82.4% complete ...
Struggling with bladder leaks? Learn causes, pelvic floor exercises, and practical ways to manage urinary incontinence.
In consideration of visiting the loo “just in case,” the behavior seems to be sound advice, from before long car rides, presentations, or exercise, but Dr. Daria Sadovskaya expresses that this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results